Facebook
Twitter
LinkedIn
Forward
Mayo Clinic Angiogenesis and Tumor Microenvironment Symposium: From Translational Research to Precision Clinical Practice 2016
Course Director: Debabrata Mukhopadhyay, Ph.D.
Co-Course Directors: Asher Chanan-Khan, M.D., Leslie Cooper, Jr., M.D.
The main goal of our symposium is to bring together basic scientists and clinical experts in the field of angiogenesis, microenvironment, cancer and cardiovascular to facilitate the exchange of ideas and science involving basic biology and pathways of angiogenesis and microenvironment in disease processes that can be used for specific targeting of microenvironment of different diseases to build precision therapy. Clinician scientists will present the results of ongoing clinical trials on anti-angiogenesis, microenvironment targeting and related therapies and discuss cardio-toxicity related to those treatments. The course will also discussed the novel genetic and imaging methods to assess tumor vasculature or stroma for monitoring the effectiveness of angiogenesis or stromal response in the pre-clinical and clinical trials to develop more effective individualized medicine regimen for the patients. In addition, the symposium will assist in establishing strong collaborations among leading national, international, and Mayo Clinic experts in the related field.
Registration Fee
| Full Fee: M.D., D.O., Scientist | $500.00 |
| Reduced Fee: Nurse, NP, PA, Allied Health Professional | $375.00 |
Lodging Accommodation
Ritz Carlton, Amelia Island, Florida
For guests that prefer to call in to make their reservation via phone, we have a dedicated group desk available to accommodate them at 866-763-2960 please reference the group name Mayo Clinic Angiogenesis Biannual Symposium when making reservations. Or you can make your reservation online.
Additional Information
Program Schedule
Abstract Form - REGISTER AND SUBMIT YOUR ABSTRACT BY November 4, 2016
Course Brochure
AMA Credit:
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mayo Clinic College of Medicine designates this live activity for a maximum of 18.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Exhibit Opportunity
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibiting at this course, please complete the attached exhibit forms and submit to Colleen Allen.
Target Audience
This course is designed for
- Clinicians involved in cancer-related practice or research
- Laboratory scientists
- Translational researchers
- Industry partners
- Graduate or medical students
- Postdoctoral fellows or residents
Others with an interest or with backgrounds in cardiovascular biology and developmental biology, myeloma, cancer, angiogenesis and related clinical trials, lymph angiogenesis, extracellular matrix, and anti-angiogenic therapy in differential tumors.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Assess the role of angiogenesis in different pathological situations.
- Analyze the molecular pathways in angiogenesis.
- Identify the importance of angiogenesis in cancer progression and metastasis.
- Evaluate angiogenesis as a potential target for future cancer therapy.
- Establish the therapeutic potential of anti-angiogenic molecules and translate basic science to clinical applications.
- Evaluate state-of-the-art technologies as they relate to therapeutic strategies against tumor microenvironment and angiogenesis in tumors and defined diseases.
- Identify the current challenges of anti-angiogenic therapies in clinical outcomes of anti-angiogenic therapy that lead to better drug discoveries.
Available Credit
- 18.25 AMA PRA Category 1 Credit™